Barclays PLC Logic Bio Therapeutics, Inc. Transaction History

Barclays PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.35 - $0.74 $1,933 - $4,088	-5,525 Reduced 64.67%	3,018 $1,000
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $3,850 - $15,719	-6,313 Reduced 42.49%	8,543 $6,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $5,634 - $11,601	-2,561 Reduced 14.7%	14,856 $34,000
Q3 2021 Nov 09, 2021	SELL	$3.85 - $5.09 $6,133 - $8,108	-1,593 Reduced 8.38%	17,417 $80,000
Q2 2021 Aug 13, 2021	SELL	$4.03 - $7.57 $38,514 - $72,346	-9,557 Reduced 33.45%	19,010 $84,000
Q1 2021 May 13, 2021	BUY	$6.8 - $9.16 $57,235 - $77,099	8,417 Added 41.77%	28,567 $208,000
Q4 2020 Feb 11, 2021	BUY	$5.29 - $9.1 $61,660 - $106,069	11,656 Added 137.23%	20,150 $154,000
Q3 2020 Nov 12, 2020	BUY	$5.41 - $9.45 $10,214 - $17,841	1,888 Added 28.58%	8,494 $77,000
Q2 2020 Aug 12, 2020	BUY	$4.25 - $8.46 $16,477 - $32,799	3,877 Added 142.07%	6,606 $56,000
Q1 2020 May 13, 2020	SELL	$4.06 - $11.0 $22,626 - $61,303	-5,573 Reduced 67.13%	2,729 $14,000
Q4 2019 Feb 10, 2020	BUY	$7.01 - $11.01 $29,820 - $46,836	4,254 Added 105.09%	8,302 $60,000
Q3 2019 Nov 14, 2019	SELL	$6.97 - $13.46 $9,360 - $18,076	-1,343 Reduced 24.91%	4,048 $44,000
Q2 2019 Aug 14, 2019	BUY	$9.77 - $17.08 $31,029 - $54,246	3,176 Added 143.39%	5,391 $70,000
Q1 2019 May 15, 2019	BUY	$7.93 - $10.41 $1,720 - $2,258	217 Added 10.86%	2,215 $22,000
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $15,744 - $35,924	1,998 New	1,998 $21,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.